A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem™ PT).

Chris GardinerK KohamaI PatelP LaneS DwyerS J MachinI J Mackie

Published in: International journal of laboratory hematology (2017)

Revohem™ PT showed comparable or improved performance relative to two widely used reagents and is suitable for use in warfarin control, detection of inherited factor II, V, VII and X deficiency and assessment of liver disease coagulopathy.

Keyphrases

endothelial cells
atrial fibrillation
venous thromboembolism
direct oral anticoagulants
pluripotent stem cells
loop mediated isothermal amplification
label free
cell free
quantum dots
clinical evaluation